Outcomea | N (%), Median (IQR) |
---|---|
Mortality | |
in ICU | 8 (7) |
in hospital | 15 (13) |
at 90 days | 17 (15) |
Length of stay (in days) | |
in ICU | 8 (4–20) |
in hospital | 20 (12–42) |
Duration of life support (in days) | |
mechanical ventilation | 8 (3–21) |
Relapse of bacteremia | 4 (4) |
Antibiotic-free days (by day 30) | 14 (8–17) |
Antimicrobial-related adverse outcomes | |
Allergy | 0 (0) |
Anaphylaxis | 0 (0) |
Acute kidney injury | 0 (0) |
Acute hepatitis | 1 (1) |
Clostridium difficile infection | 4 (4) |
Secondary infection with highly resistant microorganisms | 10 (9) |